You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

Glenmark Gets Tentative FDA Approval for Generic Breast Cancer Injection Drug, an Industrial Info Market Brief

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 100 Words

Indian pharmaceutical manufacturer Glenmark Pharmaceuticals Limited on Friday said its U.S.-based subsidiary, Glenmark Pharmaceuticals Incorporated, has received tentative approval from the U.S. Food and Drug Administration (FDA) for the injectable drug Fulvestrant.

Subscribe Now! All Fields Required...

Standard Membership - Free